Advertisement

Topics

STAT Plus: European regulators suspend use of MRI drugs, but why hasn’t the FDA?

15:26 EDT 2 Aug 2017 | STAT

Last month, European regulators suspended three contrast agents over concerns about a potentially toxic metal that can be left in brain tissue.

Original Article: STAT Plus: European regulators suspend use of MRI drugs, but why hasn’t the FDA?

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: European regulators suspend use of MRI drugs, but why hasn’t the FDA?"

Quick Search
Advertisement